Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 31 min 43 sec ago

Dassault Systèmes Announces Commercial Availability of Its First Simulated Human Heart

Wed, 05/20/2015 - 13:48
Scientifically Accurate 3D Model Accelerates Device Testing and Research for Treatment of Heart Disease ÉLIZY-VILLACOUBLAY, France & BERLIN--(Healthcare Sales & Marketing Network)--Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY...
Devices, Cardiology, Product Launch
Dassault Systèmes, Living Heart Project

Post-Market Study Evaluating The Boston Scientific Lotus(TM) Valve System Demonstrates Extremely Low PVL Rates

Wed, 05/20/2015 - 13:39
Compelling Results Presented at EuroPCR 2015 Add to Growing Body of Evidence Supporting Performance and Safety MARLBOROUGH, Mass., May 20, 2015 -- (Healthcare Sales & Marketing Network) -- A new study evaluating the Boston Scientific (BSX) Lotus™ Valve...
Devices, Interventional Cardiology
Boston Scientific, Lotus Valve, transcatheter, aortic valve, TAVI

Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease

Tue, 05/19/2015 - 15:38
Support from Blue-Chip Financial and Strategic Investors Will Advance Product and Clinical Development FREMONT, Calif.--(Healthcare Sales & Marketing Network)--Shockwave Medical, a pioneer in the treatment of peripheral and coronary vascular disease, to...
Devices, Interventional, Cardiology, Venture Capital
Shockwave Medical, Lithoplasty

Vascular Pathways, Inc. Signs Agreement With HealthTrust for AccuCath(R) Line of Catheters

Tue, 05/19/2015 - 15:32
BOCA RATON, FL--(Healthcare Sales & Marketing Network) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire-guided technology for peripheral intravascular access, today announced an agreement with HealthTrust, a lead...
Devices, Group Purchasing
Vascular Pathways, HealthTrust, AccuCath

Court Upholds Award of $467 Million to Masimo for Philips' Patent Infringement

Tue, 05/19/2015 - 15:28
IRVINE, CA--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI), inventor of breakthrough noninvasive Measure-through Motion and Low Perfusion™ pulse oximetry and rainbow® Pulse CO-Oximetry™, announced today that the Delaware federal court u...
Devices, Monitoring, Litigation
Masimo, Philips, pulse oximeter, pulse oximetry, rainbow pulse CO-Oximetry

FDA Grants Premarket Approval for Silk Road Medical's ENROUTE(R) Transcarotid Stent System

Tue, 05/19/2015 - 15:23
First Carotid Stent Indicated for Transcarotid Use and Optimized for Novel TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., May 19, 2015 -- (Healthcare Sales & Marketing Network) -- Silk Road Medical, Inc., a pioneer in the dev...
Devices, Interventional, FDA
Silk Road Medical, Transcarotid Stent

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

Tue, 05/19/2015 - 15:15
More Than 100,000 People with Coronary Artery Disease Have Been Treated with Absorb Abbott on Track to Submit for Regulatory Approvals of Absorb in the U.S., Japan and China PARIS, May 19, 2015 -- (Healthcare Sales & Marketing Network) -- Abbott ann...
Devices, Interventional Cardiology, Regulatory
Abbott, Absorb stent, Absorb GT1, GlideTrack

Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)

Tue, 05/19/2015 - 14:35
Triptorelin 6-month formulation phase III trial demonstrates good efficacy in terms of pituitary and gonadal suppression and in arresting or reversing progression of clinical signs of puberty and slowing down of accelerated bone maturation in children with...
Debiopharm Group, Triptorelin, central precocious puberty

Apollo Endosurgery, Inc. Announces the Presentation of ORBERA(TM) Intragastric Balloon US Pivotal Trial Results at Digestive Disease Week(R) 2015 Conference (DDW)

Mon, 05/18/2015 - 15:41
AUSTIN, Texas--(Healthcare Sales & Marketing Network)--Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, today announced the presentation of results from the ORBERA™ Pivotal...
Devices, Gastroenterology
Apollo Endosurgery, ORBERA, Intragastric Balloon

Vesiflo Introduces the inFlow Device and Its Companion Patient Monitoring System

Mon, 05/18/2015 - 15:36
NEW ORLEANS--(Healthcare Sales & Marketing Network)--Leveraging the growth of mobile apps, wearables and cloud services, Vesiflo previewed the inFlow™ urinary prosthesis for women and its companion app/information system at the American Urological Associat...
Devices, Urology, Product Launch
Vesiflo, inFlow Patient Support System, impaired detrusor contractility

Clarus Ventures Promotes Michele Park, Ph.D., to Partner

Mon, 05/18/2015 - 15:33
CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 18, 2015 -- (Healthcare Sales & Marketing Network) -- Clarus Ventures, a leading life science investment firm, announced today the promotion of Michele Park, Ph.D., to Partner. Michele is based in the...
Biopharmaceuticals, Devices, Venture Capital, Personnel
Clarus Ventures

Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease

Mon, 05/18/2015 - 15:29
NAMZARIC is now available across the United States DUBLIN, Ireland, May 18, 2015 -- (Healthcare Sales & Marketing Network) -- Actavis plc (ACT) today announced that NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a onc...
Biopharmaceuticals, Neurology, Product Launch
Actavis, AMZARIC, memantine, donepezil, Alzheimer's Disease

Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany

Fri, 05/15/2015 - 13:50
Germany is the first country in which Xadago® is available as an add-on to levodopa alone and in combination with other PD medications MILAN--(Healthcare Sales & Marketing Network)--Zambon S.p.A., an international pharmaceutical company strongly com...
Biopharmaceuticals, Neurology, Product Launch
Newron Pharmaceuticals, Xadago, safinamide, Parkinson’s disease

Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing

Fri, 05/15/2015 - 13:40
Cortendo Enters Into Agreements to Acquire Aspireo Pharmaceuticals' Somatoprim (DG3173) and In-License Antisense Therapeutics' ATL1103 Cortendo Expands Investor Base Through New Private Placement GÖTEBORG, Sweden & TREVOSE, Pa.--(Healthcare Sale...
Biopharmaceuticals, Acquisitions, Licensing, Venture Capital
Cortendo AB, Aspireo Pharmaceutical, Somatoprim, acromegaly

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong